In patients with an atrial septal defect (ASD) and left ventricular (LV) dysfunction associated with coronary artery disease (CAD), to avoid the development of acute left heart failure (HF) and an increase in myocardial oxygen consumption following ASD closure, it is conceivable that coronary artery revascularization should be performed prior to ASD closure. We report the case of a 67-year-old man with a large secundum ASD and LV ejection fraction of 15.6% resulting from severe ischemic cardiomyopathy and triple-vessel CAD, both of which contributed to biventricular HF characterized by high left-to-right shunt (Qp:Qs of 7.1:1) and low systemic cardiac output. After evaluating his hemodynamics and biventricular function with cardiac catheterization and cardiovascular magnetic resonance imaging, we successfully conducted an inverse, stepwise strategy of transcatheter ASD closure using anti-congestive therapies, intraaortic balloon pumping, and subsequent balloon occlusion testing, followed by on-pump beating-heart coronary artery bypass grafting.
T ranscatheter closure of an atrial septal defect (ASD) is a less invasive alternative treatment to surgery for a secundum ASD with appropriate rims. 1, 2) Recently, with the increase in the elderly population, acute left heart failure (HF) after transcatheter, as well as surgical, ASD closure has been recognized as an ongoing, important pathophysiology of ASD associated with left ventricular (LV) dysfunction, and especially with coronary artery disease (CAD). 3, 4) In previous studies, for patients with an ASD complicated with LV dysfunction and CAD, because of concerns about the development of acute left HF and an increase in myocardial oxygen consumption following ASD closure, coronary artery revascularization prior to ASD closure is recommended rather than a simultaneous or inverse approach. 5, 6) Herein, we report the case of a large ASD complicated with severe ischemic cardiomyopathy (ICM) resulting from a triplevessel disease in a 67-year-old man, for whom we adopted the inverse strategy of transcatheter ASD closure prior to coronary artery bypass grafting (CABG), based on an assessment of the patient's hemodynamics and biventricular function.
Case Report
A 67-year-old man, with a medical history of insulindependent diabetes mellitus (IDDM), hypertension, and dyslipidemia, was admitted to our hospital for further evaluation of HF symptoms of New York Heart Association functional class III, severe LV dysfunction, and suspected triple-vessel CAD on coronary computed tomography angiography. He presented with a high brain natriuretic peptide level (324.0 pg/mL), blood pressure of 93/65 mmHg, and arterial oxygen saturation of 96% in room air. Chest radiography revealed cardiomegaly (cardiothoracic ratio of 57.3%) with dilated pulmonary vessels, and electrocardiography revealed atrial fibrillation with a ventricular heart rate of 92 beats/min and complete right bundle branch block with right axis deviation. Transthoracic and transesophageal echocardiography demonstrated biven-TRANSCATHETER ASD CLOSURE AND SEVERE ICM (Table I) , along with extensive, partially transmural late gadoliniumenhancement in the LV wall ( Figure 2 ). Cardiac catheterization revealed a mean pulmonary arterial pressure (PAP) of 25 mmHg, markedly elevated shunt volume (Qp:Qs) of 7.1:1 with a reduced systemic cardiac index of 1.38 L/ minute/m 2 , and compensated LV end-diastolic pressure of 6 mmHg (Table II) . Coronary angiography demonstrated subtotal occlusion in the mid right coronary artery, total occlusion in the proximal left anterior descending artery with 90% stenosis in the first diagonal branch, and 90% stenosis in the mid left circumflex coronary artery with total occlusion in its posterolateral branch ( Figure 3 ). Subsequently, the SYNTAX score was calculated as 58. Thus, we made a diagnosis of a hemodynamically significant large ASD and severe ICM due to a triple-vessel disease, both of which contributed to biventricular HF characterized by a markedly high left-to-right shunt and low systemic cardiac output. We evaluated possible treatment strategies within the multidisciplinary heart team. Regarding coronary artery revascularization, CABG was recommended because of the high SYNTAX score and the presence of IDDM, 7) where we selected not off-pump CABG (OPCAB) but on-pump beating-heart CABG because of concerns about high risk of conversion to on-pump CABG during OPCAB owning to a severe triple-vessel disease, a * shunt volume (Qp/Qs) was calculated by using oxygen saturation of aorta (96.7%) as a substitute of pulmonary vein, based on the assumption that oxygen saturation of pulmonary vein was comparable to that of aorta. PAWP indicates pulmonary artery wedge pressure; PAP, pulmonary arterial pressure; RAP, right atrial pressure; LAP, left atrial pressure; LVEDP, left ventricular end-diastolic pressure; AoP, aortic pressure; Qp/Qs, pulmonary to systemic flow ratio; PVR, pulmonary vascular resistance; and PA, pulmonary artery.
very low LVEF, and high age 8) and also potential technical limitation of OPCAB in this large heart, as evidenced by CMR imaging. The anatomy of the ASD was suitable for transcatheter closure. Although the simultaneous surgical approach of ASD closure and CABG was considered, the perioperative mortality risk was considerably high as estimated by Euro SCORE II of 15.4%. In addition, because of concerns about potential difficulties in the postoperative intensive care under an untreated large ASD with residual low systemic cardiac output, preceding CABG followed by transcatheter ASD closure was excluded. Finally, we decided on the stepwise hybrid strategy of transcatheter ASD closure using anti-congestive therapies, intraaortic balloon pumping (IABP), and subsequent balloon occlusion testing, followed by on-pump beating-heart CABG. We started anti-congestive therapies with dobutamine infusion, angiotensin-converting enzyme inhibitor, and oral diuretics by 48 hours before the procedure to prevent pulmonary edema following ASD closure. Under general anesthesia, we introduced IABP to prevent the exacerbation of myocardial ischemia owing to a marked increase in LV preload following ASD closure, as evidenced by Qp:Qs of 7.1:1. During a 15-minute balloon occlusion of the ASD, we monitored the diastolic PAP as a substitute of the left atrial pressure (LAP), which decreased rather than increased (Table II) Table I ), when the scheduled on-pump beating-heart CABG was successfully performed by experienced surgeons. Five months after both of the procedures, RVEDVI decreased further to 83.2 mL/m 2 , within the normal range, with an increase in the LVEF to 20.0% (Table I) .
Discussion
To the best of our knowledge, this is the first report to demonstrate (1) a large ASD complicated with severe ICM with a very low LVEF of 15.6% in an elderly patient, and (2) for whom ASD device closure was conducted successfully prior to surgical coronary revascularization in the setting of severe LV dysfunction and a triplevessel disease, using anti-congestive therapies, IABP, and balloon occlusion testing.
Aging, systemic hypertension, and decreased LV compliance increase left-to-right shunt through an ASD over time. 6, 9) Therefore, with the increase in the elderly population, it has become necessary to clarify how to manage patients with an ASD associated with LV dysfunction, including a masked decreased LV compliance and restriction. 3, 6) Several reports have described elderly patients with an ASD and LV dysfunction with CAD. 4, 5, 10) Bartel, et al. reported a successful transcatheter ASD closure for a 67-year-old man with severe ICM (LVEF of 21%) resulting from two old myocardial infarctions, using anti-congestive therapies and balloon occlusion testing. 10) However, few reports have precisely evaluated volumes and function of both of the ventricles, including myocardial changes, before and after ASD closure using CMR, a more reproducible modality for assessing both of the ventricles compared to echocardiography. 11, 12) In the present report, we described a 67-year-old man with a large ASD and a very low LVEF (15.6%) due to severe ICM and a triple-vessel disease, resulting in a markedly high left-toright shunt and low systemic cardiac output. These findings indicated the coexistence of severe LV systolic dysfunction and prominent right heart volume overload in this patient, which was well demonstrated by CMR. This case suggests the importance of precisely evaluating the hemodynamics and biventricular volumes and function with CMR in combination with cardiac catheterization, before selecting an optimal treatment strategy.
Generally, in ASD complicated with such severe LV dysfunction and CAD, to avoid the development of acute left HF and an increase in myocardial oxygen consumption following ASD closure, it is conceivable that coronary artery revascularization should be performed prior to ASD closure. 5, 6) Onorato, et al. reported successful sequential percutaneous coronary intervention (PCI) for CAD and transcatheter ASD closure in 6 cases with angina pectoris, where four patients underwent PCI prior to ASD closure. 13) Tomai, et al. reported an unsuccessful case that developed acute left HF after a simultaneous approach of PCI and transcatheter ASD closure. 4) They proposed possible reasons for the development of acute left HF such as myocardial stunning following PCI adding to the mildly reduced LVEF at the baseline. In our case, three treatment strategies are possible. For a simultaneous surgical approach of ASD closure and CABG, because of the severely impaired LV function and the presence of several comorbidities such as IDDM, chronic kidney disease, and prior cerebral infarction, atherosclerosis obliterans, severe frailty, and his age, the perioperative mortality risk was considered to be high (calculated as 15.4% via Konagai, ET AL Euro SCORE II). Preceding on-pump beating-heart CABG followed by transcatheter ASD closure was considered; however, a remaining large ASD has the potential to cause hemodynamic instability (low systemic cardiac output) and poor oxygenation response to positive end-expiratory pressure via increased right-to-left shunt during the postoperative period, both of which may result in prolonged invasive mechanical ventilation. Finally, we opted for the inverse, stepwise hybrid strategy of transcatheter ASD closure using anti-congestive therapies, IABP, and subsequent balloon occlusion testing, followed by on-pump beatingheart CABG.
In this case, the anti-congestive therapies and balloon occlusion testing were the key determinants for the successful ASD closure. Previous studies suggest the effectiveness of anti-congestive therapies 48-72 hours before the ASD closure to enable the LV to adapt to an increased preload, and these therapies consisted of inotropic agents, diuretics, and vasodilators. 14) In addition, balloon occlusion testing is reportedly useful for identifying patients who are likely to develop pulmonary edema following device closure. 3, 5, 14) Schubert, et al. defined an increase in mean LAP exceeding 10 mmHg as LV restrictive physiology. 14) Furthermore, if the increase in mean LAP exceeded 10 mmHg or significant ischemic change in electrocardiography was detected during temporary ASD occlusion, we would suspend the procedure, which is the considerable advantage of device closure over surgery in treating an ASD associated with LV dysfunction. Finally, we used IABP perioperatively to prevent the worsening of myocardial ischemia related to a marked increase in LV preload, an elevated LV end-diastolic pressure, and subsequent increased myocardial oxygen consumption following ASD closure under untreated severe triple-vessel CAD, rather than to prevent acute left HF. Further studies are needed to clarify how to manage patients with adult congenital heart disease (ACHD) and CAD, because the recent study of the national CONgenital CORvitia (CONCOR) registry reported the limited number of those patients as follows: of 6904 ACHD patients, there 55 cases (0.8%) with CAD. 15) Collectively, we could perform transcatheter ASD closure in severe ICM and untreated triple-vessel CAD prior to CABG, appropriately using anti-congestive therapies, IABP, and balloon occlusion testing without the worsening of acute left HF or myocardial ischemia. The treatment strategy was determined based on the preassessment of biventricular function with CMR and risk evaluation by the multidisciplinary heart team.
In conclusion, our report suggests that physicians should be aware that, as long as a treatment strategy is determined based on the detailed assessment of hemodynamics and biventricular function, as well as risk evaluation by the multidisciplinary heart team, coronary revascularization does not always need to precede ASD closure in an ASD complicated with LV dysfunction and CAD.
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